Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved publishing date : 2021 - 07 - 22 save search
UFPI board approves quarterly dividend of $0.15 per share
Published: 2021-07-22 (Crawled : 22:00) - globenewswire.com
UFPI 4 | $111.72 0.97% 50K
|
Non-Energy Minerals
|
| O: 0.38%
H: 0.7%
C: -0.59%
approval
National Comprehensive Cancer Network® Adds Newly Approved Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) to Clinical Practice Guidelines in Oncology for Acute Lymphoblastic Leukemia
Published: 2021-07-22 (Crawled : 21:00) - biospace.com/
JAZZ | $110.6 1.22% 210K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: -1.69%
cancer leukemia
Humanigen’s Partner in South Korea Receives Ministry of Food and Drug Safety (MFDS) Approval to Conduct Phase 1 Study of Lenzilumab
Published: 2021-07-22 (Crawled : 15:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.0%
H: 1.65%
C: -0.06%
food phase 1 lenzilumab drug approval phase 2
NRx Pharmaceuticals Announces First Successful Commercial Formulation for ZYESAMI™ (aviptadil), Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory Approval
Published: 2021-07-22 (Crawled : 12:00) - biospace.com/
NRXP 1 d | $3.005 -0.5% 170K
|
Manufacturing
|
| O: 15.43%
H: 56.64%
C: 40.96%
covid approval aviptadil commercialization
FDA Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma
Published: 2021-07-22 (Crawled : 12:00) - biospace.com/
MRK | $125.31 0.06% 2.3M
|
Health Technology
|
| O: 0.27%
H: 0.25%
C: -0.09%
fda trial fda approval keytruda
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-22 (Crawled : 11:36) - fda.gov
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.0%
H: 1.02%
C: 0.51%
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: -0.03%
H: 1.28%
C: 1.22%
ADCT | $4.86 2.1% 120K
|
Health Technology
|
| O: 0.18%
H: 0.31%
C: -2.26%
YMAB | $14.955 -0.3% 120K
|
Health Technology
|
| O: -1.57%
H: 3.71%
C: 0.43%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.45%
H: 0.12%
C: -0.6%
REGN | $894.71 0.08% 180K
|
Health Technology
|
| O: -0.36%
H: 1.56%
C: 0.9%
KPTI | $1.255 -1.95% 620K
|
Health Technology
|
| O: -0.53%
H: 0.38%
C: -3.01%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: -0.39%
H: 0.11%
C: -0.27%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -1.49%
H: 2.0%
C: -2.34%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.0%
H: 0.58%
C: -3.46%
BPMC | News | $86.27 -2.96% 230K
|
Health Technology
|
| O: -0.84%
H: 1.72%
C: 0.61%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 2.21%
H: 0.0%
C: -4.87%
cancer approval
Cybin Announces Conditional Listing Approval from NYSE American
Published: 2021-07-22 (Crawled : 07:00) - biospace.com/
CYBN | News | $0.3669 -0.81% 1.2M
|
n/a
| Email alert
Add to watchlist
approval
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
RWOD | $10.08 26.05% 5.6M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.